Aarti Drugs Ltd Q1, Q2, Q3, Q4, FY 2017-18, FY 2016-17 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Aarti Drugs Ltd Company Profile :

Aarti Drugs Ltd is one of the leading pharmaceutical manufacturers in India. It is part of the USD 500 million Aarti Group of Industries.

Aarti Drugs is engaged in the business of manufacturing of pharmaceuticals. The company operates in the anti-diarrhea, anti-inflammatory and anti-biotic therapeutic segments. With its manufacturing facilities at Tarapur and Sarigam, the Company manufactures Vitamins, Anti-arthritis, Anti-fungal, Antibiotics, ACE inhibitors, besides its range in , anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs.


Aarti Drugs ResultsBSE Code : 524348
NSE Symbol : AARTIDRUGS
ISIN No. : INE767A01016
Industry : Pharmaceuticals
Face Value : Rs. 10.00


If you are an investor who has shares of Aarti Drugs or you are an stock market analyst then i am sure you might for Quarterly Results of Aarti Drugs.

In this article you will find Q1, Q2, Q3, Q4 and FY 2017-18 Results of Aarti Drugs. That’s not all, you can compare those results with previous year i.e., FY 2016-17 Results of Aarti Drugs.

Aarti Drugs Q1 Results 2017-18 :

3M India will announce its Q1 FY 2017-18 Results in August 2017. Will soon update the below mentioned table.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue 248.26
Other Income  0.06
Total Income  248.32
Expenditure  -223.54
Interest  -8.46
Depreciation  -9.26
PBT  15.52
Tax  -4.95
Net Profit  10.57
Equity  –
EPS  4.43

Aarti Drugs will announce its Q2 FY 2017-18 Results in the month of October 2017.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Aarti Drugs will announce its Q3 FY 2017-18 Results in the month of January 2018.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Aarti Drugs will announce its Q4 FY 2017-18 Results in the month of April 2018.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Aarti Drugs will announce its FY 2017-18 Results in the month of April 2018.

(Values in Cr.) FY 2017-18 Standalone FY 2017-18 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Aarti Drugs Previous Year’s Results (FY 2016-17) :

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue  1092.25
Other Income  –
Total Income  1092.25
Expenditure  -949.03
Interest  -34.48
Depreciation  -36.69
PBT  106.53
Tax  -32.30
Net Profit  74.23
Equity  23.86
EPS  30.78

Note : If you like this information about Aarti Drugs Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.